We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODFL icon
4126
CALL
Old Dominion Freight Line
ODFL
$44.8B
$222K ﹤0.01%
7,800
+4,200
+117% +$124K
SAND
4127
DELISTED
Sandstorm Gold
SAND
$222K ﹤0.01%
52,036
+28,390
+120% +$125K
STNG icon
4128
PUT
Scorpio Tankers
STNG
$3.71B
$222K ﹤0.01%
+5,000
New +$208K
UGI icon
4129
CALL
UGI
UGI
$7.62B
$222K ﹤0.01%
4,500
-1,000
-18% -$47.5K
IMMU
4130
PUT
DELISTED
Immunomedics Inc
IMMU
$222K ﹤0.01%
34,300
-3,600
-9% -$18.2K
CTMX icon
4131
CytomX Therapeutics
CTMX
$729M
$221K ﹤0.01%
12,820
+12,591
+5,498% +$166K
ELF icon
4132
e.l.f. Beauty
ELF
$5.09B
$221K ﹤0.01%
7,682
+7,499
+4,098% +$203K
HOPE icon
4133
Hope Bancorp
HOPE
$1.82B
$221K ﹤0.01%
11,531
-1,413
-11% -$29.7K
NTB icon
4134
Bank of N.T. Butterfield & Son
NTB
$2.45B
$221K ﹤0.01%
+6,921
New +$226K
SNBR
4135
DELISTED
Sleep Number
SNBR
$221K ﹤0.01%
8,880
-37,429
-81% -$839K
GBT
4136
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$221K ﹤0.01%
6,000
+5,000
+500% +$126K
CORE
4137
DELISTED
Core Mark Holding Co., Inc.
CORE
$221K ﹤0.01%
7,098
+6,395
+910% +$224K
NG icon
4138
NovaGold Resources
NG
$3.02B
$220K ﹤0.01%
45,297
+7,492
+20% +$39.6K
INSY
4139
DELISTED
Insys Therapeutics, Inc.
INSY
$220K ﹤0.01%
21,027
+6,784
+48% +$72.3K
JOY
4140
CALL
DELISTED
Joy Global Inc
JOY
$220K ﹤0.01%
7,800
-9,600
-55% -$270K
MCFT icon
4141
MasterCraft Boat Holdings
MCFT
$610M
$219K ﹤0.01%
13,538
+13,138
+3,285% +$196K
RAMP icon
4142
CALL
LiveRamp
RAMP
$2.3B
$219K ﹤0.01%
7,700
-3,900
-34% -$109K
XHR
4143
Xenia Hotels & Resorts
XHR
$1.89B
$219K ﹤0.01%
12,809
-273
-2% -$4.9K
CCP
4144
DELISTED
Care Capital Properties, Inc.
CCP
$219K ﹤0.01%
8,149
-43,401
-84% -$1.09M
FHI icon
4145
Federated Hermes
FHI
$4.78B
$218K ﹤0.01%
8,284
-67,869
-89% -$1.82M
IWD icon
4146
CALL
iShares Russell 1000 Value ETF
IWD
$83.2B
$218K ﹤0.01%
1,900
+700
+58% +$80.3K
IMGN
4147
DELISTED
Immunogen Inc
IMGN
$218K ﹤0.01%
56,377
+38,789
+221% +$113K
AUY
4148
PUT
DELISTED
Yamana Gold, Inc.
AUY
$218K ﹤0.01%
79,100
-34,900
-31% -$106K
RRTS
4149
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$218K ﹤0.01%
1,267
+326
+35% +$67.3K
APTI
4150
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$218K ﹤0.01%
18,611
+17,907
+2,544% +$259K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.